FDA STATE_REFERRAL_LETTER - Fairview Compounding Pharmacy - April 09, 2018

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This STATE REFERRAL LETTER record concerns Fairview Compounding Pharmacy, with an inspection on April 9, 2018, issued by the Office of Regulatory Affairs.

Company: Fairview Compounding Pharmacy
Inspection Date: April 9, 2018
Office: Office of Regulatory Affairs
People: Robert W. Beacher
Stacey Jassey
Art O. Czabaniuk (Program Division Director)
Tina M. Pawlowski (Compliance Officer)
Nicholas F. Lyons (Director of Compliance)

Open in Dashboard

ID · 11a74d29-a9bb-4cd0-a27b-56659fefe658

Violation Codes3

21 CFR 20.64(d)(3)21 CFR 20.88FD&C Act 503A(a)

Full citation text and observation details available on the Dashboard.